Journal profile

Revista Portuguesa de Farmacoterapia

ISSN 1647-354X · eISSN 2183-7341 · Formifarma, LDA. · Portugal

Revista Portuguesa de Farmacoterapia: fully open access; no APC; review about 8 weeks (community reports); 10 articles in 2025.

Impact factor—No published value
CAS zone—Not in the CAS Journal Ranking
CiteScore quartile—No CiteScore rank
Review timeabout 8 weeksCommunity average
APCNo APCFully open access
Acceptance—No reports yet
Articles per year102025 · OpenAlex count

Scope

Aims, scope and focus

Revista Portuguesa de Farmacoterapia is published by Formifarma, LDA.. By OpenAlex counts of its recent articles, its largest topics are Healthcare Regulation, Pharmaceutical Economics and Policy and Health Systems, Economic Evaluations, Quality of Life, together about 35.6% of its articles. (generated from OpenAlex topic counts and CAS ranking data)

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Healthcare RegulationHealth Professions15.6%
  2. Pharmaceutical Economics and PolicyEconomics, Econometrics and Finance11.1%
  3. Health Systems, Economic Evaluations, Quality of LifeEconomics, Econometrics and Finance8.9%
  4. Health Services Management and PolicyHealth Professions6.7%
  5. Healthcare Systems and PracticesHealth Professions6.7%
  6. Healthcare Systems and ReformsEconomics, Econometrics and Finance4.4%
  7. Biomedical Ethics and RegulationMedicine4.4%
  8. Pharmacy and Medical PracticesPharmacology, Toxicology and Pharmaceutics4.4%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Not covered

Not covered by this edition.

CAS Xinrui Journal Ranking (March 2026)Not covered

Not covered by this edition.

CAS Journal Ranking, previous upgraded edition (December 2023)Not covered

Not covered by this edition.

Database indexing

Indexed in: no record yet.

International journal early-warning lists: not listed in any editionLetPub

Indexing the journal's website claims

DeCS, MeSHPublisher website

As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

h-index
0OpenAlex ·
i10-index
0OpenAlex ·
2-year mean citedness
0OpenAlex ·
Share of gold OA articles
0%LetPub ·

Articles by year OpenAlex count · 19 in total · the current year is incomplete

YearArticlesOpen accessCitations
2026440
202510100

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Average review time (community reports)
about 8 weeksLetPub ·
Peer review
Anonymous peer reviewLetPub

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Fully open accessLetPub

Every article is open access; authors usually pay an article processing charge (APC).

SourceAPCFee waiverLicenseObserved
LetPubNo APCNo—

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Submission

Article types and submission policies (journal website)

Article types accepted1
  1. artigosEm caso de submissão a uma secção com revisão por pares (ex.: artigos), as instruções disponíveis em Assegurando a Revisão Cega por Pares foram seguidas.Length not stated
Publisher website
Policy excerpts from the journal's websiteLicense & copyright
License & copyright

Creative Commons BY-NC-ND Model summary

Relativamente à utilização por terceiros a Rev Port Farmacoter rege-se pelos termos da licença Creative Commons ‘Atribuição – Uso Não-Comercial – Proibição de Realização de Obras Derivadas (by-nc-nd)’.

Source ↗Publisher website ·

Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.

Profile

Publication details and official links

Publisher
Formifarma, LDA.
Country or region
Portugal
Language
English, Portuguese
ISSN
1647-354X
Electronic ISSN
2183-7341
Official links

FAQ

Frequently asked questions about Revista Portuguesa de Farmacoterapia

How long does peer review take at Revista Portuguesa de Farmacoterapia?

Authors report an average review time of about 8 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

Is Revista Portuguesa de Farmacoterapia open access, and what is the APC?

Revista Portuguesa de Farmacoterapia is a fully open-access journal. It charges no article processing charge.

Sources and updates

The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .